![]() |
|
|
Vol. 303, Issue 2, 527-533, November 2002
Department of Chemistry, Pennsylvania State University,
University Park, Pennsylvania (E.L.U., A.M.A.); Institut National de la
Santé et de la Recherche Médicale, Marseilles, France
(P.M.-P.); and Laboratory of Clinical Science, National Institute of
Mental Health, Bethesda, Maryland (D.L.M.)
The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
analog, 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine
(2'-NH2-MPTP), depletes brain serotonin and norepinephrine
in mice without affecting striatal dopamine. The present study was
conducted to determine whether 2'-NH2-MPTP would be
similarly neurotoxic to rats. Four injections of 20 mg/kg
2'-NH2-MPTP caused 80 to 90% depletions in serotonin and
norepinephrine in frontal cortex and hippocampus in rats 1 week
post-treatment. A lower dose of 2'-NH2-MPTP (4 × 15 mg/kg)
also produced large decrements in serotonin and norepinephrine levels
and in serotonin transporter density measured 3 weeks after neurotoxin
administration. Furthermore, this lower dose of 2'-NH2-MPTP altered functional serotonin neurotransmission as evidenced by a 2-fold
potentiation of 1-(3-chlorophenyl)-piperazine·2HCl-induced hyperthermia, an index of serotonergic denervation supersensitivity. At
both doses, 2'-NH2-MPTP was without effect on striatal
dopamine. For comparison, additional rats were treated with a second
2'-substituted analog of MPTP,
1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-CH3-MPTP), at 2 × 20 mg/kg. This dosing regimen causes
substantial striatal dopamine depletion in mice.
2'-CH3-MPTP had no effect on brain levels of serotonin,
norepinephrine, or dopamine in rats. Together, these results
demonstrate that rats are sensitive to the toxic effects of
2'-NH2-MPTP but not to 2'-CH3-MPTP at doses known to cause neurotoxicity in mice. Moreover, this study clearly shows that 2'-NH2-MPTP can be utilized in rats as a tool to
study the serotonergic and noradrenergic neurotransmitter systems.
This article has been cited by other articles:
![]() |
A. L. Numis, E. L. Unger, D. L. Sheridan, A. C. Chisnell, and A. M. Andrews The Role of Membrane and Vesicular Monoamine Transporters in the Neurotoxic and Hypothermic Effects of 1-Methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP) Mol. Pharmacol., September 1, 2004; 66(3): 718 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Luellen, D. B. Miller, A. C. Chisnell, D. L. Murphy, J. P. O'Callaghan, and A. M. Andrews Neuronal and Astroglial Responses to the Serotonin and Norepinephrine Neurotoxin: 1-Methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 923 - 931. [Abstract] [Full Text] [PDF] |
||||